5 Am Venture Management, LLC Entrada Therapeutics, Inc. Transaction History
5 Am Venture Management, LLC
- $225 Million
- Q4 2024
A detailed history of 5 Am Venture Management, LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, 5 Am Venture Management, LLC holds 4,408,379 shares of TRDA stock, worth $46.2 Million. This represents 33.83% of its overall portfolio holdings.
Number of Shares
4,408,379
Previous 4,408,379
-0.0%
Holding current value
$46.2 Million
Previous $70.5 Million
8.13%
% of portfolio
33.83%
Previous 28.09%
Shares
1 transactions
Others Institutions Holding TRDA
# of Institutions
104Shares Held
28.9MCall Options Held
40.3KPut Options Held
4.1K-
Baker Bros. Advisors LP New York, NY4.87MShares$51 Million0.93% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.38MShares$46 Million60.89% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.9MShares$30.5 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X02.08MShares$21.8 Million0.02% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$17.8 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $329M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...